Cargando…

Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis

BACKGROUND: Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized by anomalies of the primary veins outside the skull that has been reported to be associated with MS. In the blinded Combined Transcranial (TCD) and Extracranial Venous Doppler Evaluation (CTEVD) stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinstock-Guttman, Bianca, Ramanathan, Murali, Marr, Karen, Hojnacki, David, Benedict, Ralph HB, Morgan, Charity, Yeh, Eluen Ann, Carl, Ellen, Kennedy, Cheryl, Reuther, Justine, Brooks, Christina, Hunt, Kristin, Elfadil, Makki, Andrews, Michelle, Zivadinov, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462121/ https://www.ncbi.nlm.nih.gov/pubmed/22587224 http://dx.doi.org/10.1186/1471-2377-12-26

Ejemplares similares

Chronic Cerebrospinal Vascular Insufficiency Is Not Associated with HLA DRB1*1501 Status in Multiple Sclerosis Patients
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2011)

Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2013)

Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers
por: Dolic, Kresimir, et al.
Publicado: (2011)

Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency
por: Zivadinov, Robert, et al.
Publicado: (2011)

Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
por: Caprio, Maria Grazia, et al.
Publicado: (2017)

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report
por: Zamboni, Paolo, et al.
Publicado: (2011)

The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging
por: Guan, Yi, et al.
Publicado: (2019)

Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study
por: Schwartz, Carolyn E., et al.
Publicado: (2015)

Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2012)

Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis
por: Malyavantham, Kishore, et al.
Publicado: (2015)

Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study
por: Schwartz, Carolyn E., et al.
Publicado: (2016)

No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years
por: Gandhi, Sirin, et al.
Publicado: (2019)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS
por: Zivadinov, Robert, et al.
Publicado: (2016)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: Results of the PREMiSe pilot study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Iron deposition and inflammation in multiple sclerosis. Which one comes first?
por: Zivadinov, Robert, et al.
Publicado: (2011)

MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy
por: Goldberg, Hila, et al.
Publicado: (2014)

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Detecting isolated cognitive relapses in persons with MS
por: Morrow, Sarah A, et al.
Publicado: (2023)

Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2020)

Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study
por: Tavazzi, Eleonora, et al.
Publicado: (2020)

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
por: Tao, Yazhong, et al.
Publicado: (2015)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature
por: Chaitanya, Ganta Vijay, et al.
Publicado: (2013)

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
por: Dwyer, Michael G., et al.
Publicado: (2015)

Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS
por: Narayanaswamy, Rohini, et al.
Publicado: (2015)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2011)

Improved cognitive performance and event-related potential changes following working memory training in patients with multiple sclerosis
por: Covey, Thomas J, et al.
Publicado: (2018)

Increased contrast enhancing lesion activity in relapsing–remitting multiple sclerosis migraine patients()
por: Graziano, Elliot, et al.
Publicado: (2015)

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β
por: Sternberg, Zohara, et al.
Publicado: (2009)

Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

Chronic Cerebrospinal Venous Insufficiency
por: Rasman, Alessandro
Publicado: (2015)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gnjh0uph0m0dreunpqbgqkbsr3